Compare Figs Inc (FIGS) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Figs Inc vs Oruka Therapeutics Inc. Common Stock — how do they compare? Figs Inc trades at $18.6 (market cap $3.10B), while Oruka Therapeutics Inc. Common Stock trades at $76.8 (market cap $5.08B). The key difference: Oruka Therapeutics Inc. Common Stock is the larger of the two by market cap, and Figs Inc is trading nearer its 52-week high, Oruka Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Figs Inc for 31 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| FIGS | ORKA | |
|---|---|---|
Market Cap | $3.10B | $5.08B |
Volume | 5,758,739 | 685,276 |
Sector | Consumer Cyclical | Health |
52-Week High | $18.63 | $113.08 |
52-Week Low | $7.38 | $26.19 |
Typical Hold Time | 31 Days | 0 Days |
Enterprise Value | $2.86B | $4.21B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FIGS stock trades at $18.00, up 1.35% on the day, with a bullish technical outlook from moving averages and strong support at $16. The company reported accelerating revenue growth to $631.10M in 2025 and has beaten earnings estimates for three consecutive quarters. Recent news highlights international expansion momentum, with Q2 2026 international sales surging 67% (Zacks Investment Research, 2026-09-02).
The investment case balances robust fundamentals against a premium valuation. Strong gross margins near 69% and raised 2026 guidance support upside, but the P/E ratio of 56.45 presents execution risk. Analyst consensus suggests a 26.4% upside to the $18.00 price target, though overbought RSI levels near 89 indicate near-term consolidation potential.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Figs Inc
FIGS Inc is a healthcare apparel company. It offers more fitted scrubs for men and women made of its proprietary fabric FIONx, which provides four-way stretch and has anti-odor, anti-wrinkle, and moisture-wicking properties.
Read more on FIGS →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
